These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Outcomes from a 12-Week, Open-Label, Multicenter Clinical Trial of Teduglutide in Pediatric Short Bowel Syndrome. Carter BA; Cohran VC; Cole CR; Corkins MR; Dimmitt RA; Duggan C; Hill S; Horslen S; Lim JD; Mercer DF; Merritt RJ; Nichol PF; Sigurdsson L; Teitelbaum DH; Thompson J; Vanderpool C; Vaughan JF; Li B; Youssef NN; Venick RS; Kocoshis SA J Pediatr; 2017 Feb; 181():102-111.e5. PubMed ID: 27855998 [TBL] [Abstract][Full Text] [Related]
49. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Jeppesen PB; Sanguinetti EL; Buchman A; Howard L; Scolapio JS; Ziegler TR; Gregory J; Tappenden KA; Holst J; Mortensen PB Gut; 2005 Sep; 54(9):1224-31. PubMed ID: 16099790 [TBL] [Abstract][Full Text] [Related]
50. Intestinal adaptation and rehabilitation in adults with short bowel syndrome. Pironi L Curr Opin Clin Nutr Metab Care; 2024 Sep; 27(5):457-461. PubMed ID: 38963563 [TBL] [Abstract][Full Text] [Related]
51. Increased intestinal absorption in the era of teduglutide and its impact on management strategies in patients with short bowel syndrome-associated intestinal failure. Seidner DL; Schwartz LK; Winkler MF; Jeejeebhoy K; Boullata JI; Tappenden KA JPEN J Parenter Enteral Nutr; 2013 Mar; 37(2):201-11. PubMed ID: 23343999 [TBL] [Abstract][Full Text] [Related]
52. Nutritional management of a patient with chronic intestinal failure and hemodialysis receiving teduglutide: A case report. Florencio Ojeda L; Domínguez Rabadán R; Laínez López M; Jaldón Hidalgo G; Rodríguez Andrés N; Penco Ramírez C; Rebollo Pérez MI Nutrition; 2023 Sep; 113():112137. PubMed ID: 37481817 [TBL] [Abstract][Full Text] [Related]
53. Short bowel syndrome: highlights of patient management, quality of life, and survival. Kelly DG; Tappenden KA; Winkler MF JPEN J Parenter Enteral Nutr; 2014 May; 38(4):427-37. PubMed ID: 24247092 [TBL] [Abstract][Full Text] [Related]
54. Citrulline correlations in short bowel syndrome-intestinal failure by patient stratification: Analysis of 24 weeks of teduglutide treatment from a randomized controlled study. Jeppesen PB; Gabe SM; Seidner DL; Lee HM; Olivier C Clin Nutr; 2020 Aug; 39(8):2479-2486. PubMed ID: 31784300 [TBL] [Abstract][Full Text] [Related]
56. Characterization of American teduglutide consumers from 2015 to 2020: A large database study. Loutfy A; Kurin M; Shah R; Davitkov P JPEN J Parenter Enteral Nutr; 2022 Mar; 46(3):646-651. PubMed ID: 34291485 [TBL] [Abstract][Full Text] [Related]
57. De Novo Development of Distal Jejunal and Duodenal Adenomas After 41 Months of Teduglutide Treatment in a Patient With Short-Bowel Syndrome: A Case Report. Pevny S; Pape UF; Elezkurtaj S; Rieger A; Jürgensen C; Blüthner E; Jochum C; Tacke F; Maasberg S JPEN J Parenter Enteral Nutr; 2021 Mar; 45(3):652-656. PubMed ID: 32740933 [TBL] [Abstract][Full Text] [Related]
58. Unexpected upper gastrointestinal polyps in patients with short bowel syndrome treated with teduglutide: need for close monitoring. de Dreuille B; Cazals-Hatem D; Ronot M; Theou-Anton N; Dermine S; Le Beyec-Le Bihan J; Billiauws L; Le Gall M; Bado A; Joly F Am J Clin Nutr; 2023 Jun; 117(6):1143-1151. PubMed ID: 37270288 [TBL] [Abstract][Full Text] [Related]
59. Teduglutide-Stimulated Intestinal Adaptation Is Complemented and Synergistically Enhanced by Partial Enteral Nutrition in a Neonatal Piglet Model of Short Bowel Syndrome. Naberhuis JK; Deutsch AS; Tappenden KA JPEN J Parenter Enteral Nutr; 2017 Jul; 41(5):853-865. PubMed ID: 26304601 [TBL] [Abstract][Full Text] [Related]
60. Teduglutide for the treatment of short bowel syndrome. Jeppesen PB Drugs Today (Barc); 2013 Oct; 49(10):599-614. PubMed ID: 24191254 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]